Heart failure trials in Israel

In Israel 22 Also abroad 1265

22 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Where
Ashkelon, Beersheba, Jerusalem, Ramat Gan
People
20,000 worldwide
Run by
Medtronic
See details and how to joinNCT00271180
No phaseTaking people
Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients
Where
Tel Aviv
Age
18 years and over
People
150
Run by
Tel-Aviv Sourasky Medical Center
See details and how to joinNCT07913152
No phaseTaking people
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
Where
Haifa, Petah Tikva
Age
21 years to 79 years
People
40 worldwide
Run by
AquaPass Medical Ltd.
See details and how to joinNCT06360380
Phase 2Taking people
Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure
Where
Be’er Ya‘aqov, Haifa, Jerusalem, Petah Tikva, Poria – Neve Oved
Age
18 years and over
People
20
Run by
Cardiac Success
See details and how to joinNCT06851949
Phase 3Taking people
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Holon, Jerusalem, Tel Aviv, Tel HaShomer
Age
Up to 18 years
People
117 worldwide
Run by
Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00
No phaseTaking people
BIO|STREAM.CSP Study
Where
Ashdod, Beersheba, Hadera, Jerusalem, Tel Aviv
Age
18 years and over
People
1,000 worldwide
Run by
Biotronik SE & Co. KG
See details and how to joinNCT07393009
Phase 3Taking people
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Where
Beersheba, Be’er Ya‘aqov, Haifa, Herzelia, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
Age
40 years and over
People
11,300 worldwide
Run by
AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00
Phase 3Taking people
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Haifa, Holon, Jerusalem, Tel Aviv, Tel HaShomer
Age
6 months to 17 years
People
111 worldwide
Run by
Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00
Phase 3Taking people
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Where
Afula, Ashkelon, Beersheba, Be’er Ya‘aqov, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Tel Aviv, Tiberias
Age
18 years to 130 years
People
3,850 worldwide
Run by
AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00
No phaseTaking people
Alleviant ALLAY-HFrEF Study
Where
Tel Aviv, Zrifin
Age
18 years and over
People
350 worldwide
Run by
Alleviant Medical, Inc.
See details and how to joinNCT06812533
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Afula, Ashdod, Beersheba, Beer Yaakov, Hadera, Haifa, Holon, Jerusalem, Safed
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseTaking people
Alleviant ALLAY-HF Study
Where
Jerusalem, Tel Aviv, Zrifin
Age
40 years and over
People
700 worldwide
Run by
Alleviant Medical, Inc.
See details and how to joinNCT05685303
No phaseTaking people
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
Where
Be’er Ya‘aqov, Haifa, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
Age
40 years to 89 years
People
10 worldwide
Run by
Magenta Medical Ltd.
See details and how to joinNCT07293923
No phaseTaking people
The Impact of Volume Overload on Obstructive Sleep Apnea in Patients With Congestive Heart Failure
Where
Jerusalem
Age
18 years and over
People
50
Run by
Itshak Amsalem
See details and how to joinNCT07601724
Phase 3Taking people
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Where
Jerusalem, Ramat Gan
Age
6 years to 11 years
People
60 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06597019
No phaseTaking people
ContraBand™: Safety & Feasibility Study (RM-20-01)
Where
Nahariya, Petah Tikva, Rehovot
Age
18 years to 85 years
People
55 worldwide
Run by
Restore Medical Ltd
See details and how to joinNCT05230745
No phaseTaking people
V-Lap System For Wirelessly Measuring And Monitoring Left Atrial Pressure (LAP) In Patients With Advance Chronic Heart Failure
Where
Petah Tikva
Age
22 years to 88 years
People
25
Run by
Vectorious Medical Technologies Ltd.
See details and how to joinNCT05448833
No phaseTaking people
Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF
Where
Haifa, Jerusalem, Poria Illit, Rehovot
Age
18 years and over
People
10
Run by
Nephronyx LTD
See details and how to joinNCT05759806
No phaseTaking people
Conservative Management of Left Ventricular Assist Device Candidates
Where
Tel Aviv
Age
18 years to 80 years
People
100
Run by
Tel-Aviv Sourasky Medical Center
See details and how to joinNCT05271214
No phaseTaking people
Evaluation and Management of Cardio Toxicity in Oncologic Patients
Where
Tel Aviv
Age
18 years and over
People
1,000
Run by
Tel-Aviv Sourasky Medical Center
See details and how to joinNCT02818517
No phaseTaking people
Evaluation and Management of Heart Failure Patients
Where
Tel Aviv
Age
18 years to 120 years
People
5,000
Run by
Tel-Aviv Sourasky Medical Center
See details and how to joinNCT03142659
No phaseEnrolling by invitation
Registry of Cardiovascular Disease Patients
Where
Tel Aviv
People
110,000
Run by
Maccabi Healthcare Services, Israel
See details and how to joinNCT01759225